SCHEMBL6031378

SCHEMBL6031378

CCOC(=O)[C@H](CCc1ccccc1)CC(=O)c1ccc(-c2ccc(N)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.58
KMT2A Q03164 2/20 0.58
MEN1 O00255 1/20 0.58
RAB9A P51151 1/20 0.46
DPP4 P27487 1/20 0.44
F2 P00734 3/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAOA P21397 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
F10 P00742 4/20 0.41
MMP12 P39900 1/20 0.41
EPHX2 P34913 1/20 0.41
PPARG P37231 1/20 0.41
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PRSS1 P07477 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1748086 1.00 NPC1 (0.58) NPC1KMT2AMEN1RAB9ADPP4
SCHEMBL1748263 0.89 KMT2A (0.57) NPC1KMT2AMEN1RAB9ADPP4
SCHEMBL5068496 0.89 KMT2A (0.57) NPC1KMT2AMEN1RAB9ADPP4
SCHEMBL13744649 0.88 NPC1 (0.50) NPC1KMT2AMEN1RAB9ADPP4
SCHEMBL4226578 0.88 NPC1 (0.60) NPC1KMT2AMEN1RAB9ALMNA
SCHEMBL5068844 0.88 NPC1 (0.60) NPC1KMT2AMEN1RAB9ALMNA
SCHEMBL1748179 0.88 NPC1 (0.43) NPC1KMT2AMEN1RAB9AF2
SCHEMBL4227356 0.87 KMT2A (0.51) NPC1KMT2AMEN1RAB9ADPP4
SCHEMBL12313908 0.85 TSHR (0.51) NPC1RAB9ADPP4MMP12
SCHEMBL1748271 0.85 NPC1 (0.55) NPC1KMT2AMEN1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633722-A2 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY Bayer Pharmaceuticals Corporation (US) 2006-03-15 EP disclosed
WO-2004100881-A2 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORPORATION (US) 2004-11-25 WO disclosed